Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Océ Terug naar discussie overzicht

Rokus van Iperen interviewed by Reuters Announ

1 Post
| Omlaag ↓
  1. Doe maar 21 september 2000 16:41
    Rokus van Iperen interviewed by Reuters Announces profit-growth target of more than 10 percent Venlo, September 21, 2000 — “We have set a profit-growth target of more than 10 percent, which may or may not include currency effects or acquisitions”, Océ Chairman Rokus van Iperen said in an interview with Reuters. Océ autonomous growth this year is five percent. Mr Van Iperen continued, “We hope we can enhance that autonomous growth next year by launching new products and increasing our activities in growth markets.” In addition to six new printers and scanners, Océ will launch as many as a dozen new software products. ‘There is no reason whatsoever to believe that profit growth will be disappointing”, said Mr. Van Iperen. “I’m clearly more optimistic than at the start of the year, and that optimism hasn’t changed since seeing our earnings for the first half of the year. The restructuring, product development, and investment in growth markets are bearing fruit. “Printing on demand (PoD) is an extremely important market for us. It’s the fastest growing segment, with annual growth of roughly 60 to 70 percent. PoD currently accounts for 10 percent of sales in Production Printing Systems (PPS) and in two years it should account for 25 percent of sales in this strategic business unit.” Océ aims to supplement its PoD assortment, which includes a range of machines that print from 440 to 1,060 pages per minute. Price competition in Document Printing Systems continues, with competition coming primarily from the other players: Xerox, Canon and HP. According to Reuters, this probably explains why Xerox is facing such difficulties. Yet there are differences between Océ and others in this market. While Xerox and Canon derive a major part of their sales from the office market, office systems account for just 50 percent of Océ total sales. In addition, Xerox and Canon are primarily active in the highly competitive low volume segments and Océ in the more-profitable higher volume segments. “The other two professional markets (Production Printing and Wide Format Printing) are stable and provide a basis for growth”, Mr. Van Iperen told Reuters. “By reducing service-cost margins we’re leaving more room to deal with fierce price competition.”
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.098
AB InBev 2 5.525
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.871
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.773
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.765
Aedifica 3 924
Aegon 3.258 322.965
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.896
Agfa-Gevaert 14 2.051
Ahold 3.538 74.343
Air France - KLM 1.025 35.222
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.046
Alfen 16 25.027
Allfunds Group 4 1.511
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.504
AMG 971 134.015
AMS 3 73
Amsterdam Commodities 305 6.738
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.027
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.787
Arcelor Mittal 2.034 320.851
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.333
Aroundtown SA 1 220
Arrowhead Research 5 9.747
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.454
ASML 1.766 108.789
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 521
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.690
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.412

Macro & Bedrijfsagenda

  1. 10 maart

    1. Industriële productie januari (NL)
    2. Handelsbalans januari (Dld)
    3. Oracle Q3-cijfers
  2. 11 maart

    1. Economische groei Q4 (Jap)
    2. Inflatie februari (NL)
    3. E.ON Q4-cijfers
    4. Henkel Q4-cijfers
    5. Volkswagen Q4-cijfers
    6. Zalando Q4-cijfers
    7. Ondernemersvertrouwen mkb februari (VS)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht